Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Diabetic Retinopathy01:27

Diabetic Retinopathy

11
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
11
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.7K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial Intelligence-Driven Differentiation Between Uveal Melanoma and Nevus Based on Fundus Photographs: A Systematic Review and Meta-Analysis.

Translational vision science & technology·2026
Same author

Retraction notice to "Evaluation of AGM and FEM method for thermal radiation on nanofluid flow between two tubes in nearness of magnetism field" [Heliyon 9 (2023) e16788].

Heliyon·2025
Same author

Human KIT Antibody Briquilimab Diminishes Anaphylactic Responses in Mice Expressing Chimeric Human-Mouse KIT.

Allergy·2025
Same author

Anti-KIT antibody, briquilimab, induces mast cell apoptosis and depletion in nonhuman primates.

The Journal of allergy and clinical immunology·2025
Same author

Association of Collapsing Glomerulopathy with Donor Apolipoprotein L1 Risk Variants in Kidney Allografts from Black Donors.

Clinical journal of the American Society of Nephrology : CJASN·2025
Same author

A Case Report and Literature Review of ANCA-Associated Vasculitis and Lupus Nephritis Overlap: Lessons in Management.

Glomerular diseases·2025

Related Experiment Video

Updated: Apr 21, 2026

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate
05:58

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate

Published on: September 11, 2013

21.7K

Exudative retinal detachment in castleman disease.

Gaetano R Barile1, Nora Khatib, Song Eun Lee

  • 1From the *Department of Ophthalmology, and †Department of Pathology, Columbia University Medical Center, New York, New York.

Retinal Cases & Brief Reports
|November 13, 2014
PubMed
Summary

Castleman disease (CD) can cause visual symptoms like retinal detachments. Systemic treatment for CD led to the resolution of these retinal issues without local therapy, highlighting a key observation for managing this rare condition.

More Related Videos

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

4.5K
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

4.6K

Related Experiment Videos

Last Updated: Apr 21, 2026

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate
05:58

Retinal Detachment Model in Rodents by Subretinal Injection of Sodium Hyaluronate

Published on: September 11, 2013

21.7K
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

4.5K
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

4.6K

Area of Science:

  • Ophthalmology
  • Hematology
  • Oncology

Background:

  • Castleman disease (CD) is a rare lymphoproliferative disorder.
  • CD can present with diverse clinical manifestations, including ocular involvement.
  • Visual symptoms and retinal disease are uncommon but significant presentations of CD.

Purpose of the Study:

  • To document a case of Castleman disease presenting with visual disturbances.
  • To describe the ocular findings, specifically retinal disease, in a patient with CD.
  • To illustrate the management and outcome of retinal manifestations in CD.

Main Methods:

  • Comprehensive clinical examination and fundus photography.
  • Advanced imaging techniques including fluorescein and indocyanine green angiography.
  • Diagnostic workup involving CT scans, blood tests, lymph node biopsy, and renal biopsy.

Main Results:

  • A patient diagnosed with Castleman disease exhibited bilateral exudative retinal detachments.
  • Systemic treatment with steroids for CD was initiated.
  • Renal failure occurred during treatment but was successfully managed with plasmapheresis.
  • The exudative retinal detachments resolved spontaneously within four weeks of systemic treatment initiation, without local ocular intervention.

Conclusions:

  • Exudative retinal detachments can be a manifestation of Castleman disease.
  • Systemic treatment for Castleman disease may lead to the resolution of associated retinal detachments.
  • Observation of retinal changes under systemic therapy is a viable approach before considering local ocular treatments for CD-related retinal disease.